Titan Pharmaceuticals Inc. (NASDAQ: TTNP)
$3.8750
+0.1650 ( +4.73% ) 8.8K
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Market Data
Open
$3.8750
Previous close
$3.7100
Volume
8.8K
Market cap
$3.58M
Day range
$3.7100 - $3.9400
52 week range
$3.5100 - $14.8000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
nt | Quarterly Reports | 1 | Nov 15, 2024 |
8-k | 8K-related | 13 | Nov 08, 2024 |
8-k | 8K-related | 13 | Oct 24, 2024 |
8-k | 8K-related | 16 | Aug 19, 2024 |
10-q | Quarterly Reports | 44 | Aug 15, 2024 |
nt | Quarterly Reports | 1 | Aug 15, 2024 |
10-q | Quarterly Reports | 46 | May 15, 2024 |
3 | Insider transactions | 1 | Apr 05, 2024 |
3 | Insider transactions | 1 | Apr 05, 2024 |
8-k | 8K-related | 17 | Apr 03, 2024 |